Journal of Occupational
Health and Epidemiology
Rafsanjan university Of medical sciences
Volume 10, Issue 2 (Spring 2021)
J Occup Health Epidemiol 2021, 10(2): 75-85 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Vazirinejad R, Khalili P, Jafarzadeh A, Shabani Z, Jamalizadeh A, Rezaei B, et al . A Contact Tracing Prospective Cohort Retrieving Epidemiological Facts on SARS-CoV-2 Transmission Aspects: A Serological Analysis in an Iranian Community. J Occup Health Epidemiol 2021; 10 (2) :75-85
URL: http://johe.rums.ac.ir/article-1-469-en.html
URL: http://johe.rums.ac.ir/article-1-469-en.html
Related article in
Google Scholar
Google Scholar
Similar articles
Reza Vazirinejad1 
, Parvin Khalili * 2, Abdollah Jafarzadeh3 , Ziba Shabani4 , Ahmad Jamalizadeh5 , Batool Rezaei6 , Hassan Ahmadnia7 , Mohammad-taghi Rezayati8 , Mohammad Ebrahimian9 , Gholamreza Mehralinasab10 , Azam Bagherizadeh9 , Shima Bazaz9 , Erfan Vazirinejad11
, Parvin Khalili * 2, Abdollah Jafarzadeh3 , Ziba Shabani4 , Ahmad Jamalizadeh5 , Batool Rezaei6 , Hassan Ahmadnia7 , Mohammad-taghi Rezayati8 , Mohammad Ebrahimian9 , Gholamreza Mehralinasab10 , Azam Bagherizadeh9 , Shima Bazaz9 , Erfan Vazirinejad11
1- Professor, Dept. of Epidemiology, School of Public Health, Social Determinants of Health Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2- Assistant Prof., Dept. of Epidemiology, School of Public Health, Social Determinants of Health Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. , parvinkhalili61@yahoo.com
3- Professor, Dept. of Immunology, Kerman University of Medical Sciences, Kerman, Iran.
4- Assistant Prof., Dept. of Infection Diseases, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
5- General Physician, Health System Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
6- BSc in Midwifery, Health System Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
7- Assistant Prof., Dept. of Epidemiology and Biostatistics, School of Public Health, Social Determinants of Health Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
8- BSc in Laboratory Sciences, Dept. of Immunology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
9- BSc in Laboratory Sciences, Pathobiological Laboratory, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
10- BSc in Disease Control, Health System Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
11- Medical Student, Medical School, University of Pecs Medical School, Pecs, Hungary.
2- Assistant Prof., Dept. of Epidemiology, School of Public Health, Social Determinants of Health Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. , parvinkhalili61@yahoo.com
3- Professor, Dept. of Immunology, Kerman University of Medical Sciences, Kerman, Iran.
4- Assistant Prof., Dept. of Infection Diseases, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
5- General Physician, Health System Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
6- BSc in Midwifery, Health System Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
7- Assistant Prof., Dept. of Epidemiology and Biostatistics, School of Public Health, Social Determinants of Health Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
8- BSc in Laboratory Sciences, Dept. of Immunology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
9- BSc in Laboratory Sciences, Pathobiological Laboratory, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
10- BSc in Disease Control, Health System Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
11- Medical Student, Medical School, University of Pecs Medical School, Pecs, Hungary.
Article history
Received: 2021/09/9
Accepted: 2021/10/28
ePublished: 2021/10/30
Accepted: 2021/10/28
ePublished: 2021/10/30
Subject:
Epidemiology
Abstract: (1247 Views)
Background: The spread of the novel coronavirus seems mysterious enough to make us double-check the indices being used to predict its transmission. In this study, serological analysis was performed to assess some metric and epidemiological aspects of the infection and its transmissibility among people in contact with SARA-CoV-2 patients.
Material and Methods: A total of 453 contacts of 40 COVID-19 patients entered this contact tracing prospective cohort study. Accordingly, SARS-CoV-2 patients were diagnosed by the real-time polymerase chain reaction testing of nasopharyngeal samples. The infectiousness history was detected by the serological testing of IgG and IgM. Trained expert team completed two questionnaires, and blood samples were taken by experts in a laboratory. Data were analyzed using SPSS V21.0 and R software.
Results: The mean ages of the SARS-CoV-2 patients and the contacts were 53.0±18.2 and 30.8±19.3 years, respectively. The overall R0 of the infection was 2.58. Household and non-household secondary attack rates (SAR) were 20% (95%CI; 12.7–27.3) and 11.3% (95%CI; 6.1-16.5), respectively. The transmission probability of each contact was 0.0205, and the serial interval was 6.4±4.6 (95% CI; 5.2–7.6) days. The SAR was higher among the contacts who were exposed to asymptomatic primary cases (28%, 95%CI; 10-46%) than (13.8%, 95%CI; 9.4-18.2) among those exposed to symptomatic patients.
Conclusions: It is concluded that the herd immunity of 60 to 65% is needed in human communities, based on the amount of R0 estimated in our survey. The findings demonstrated the amount of the reduction in infection R0, which is predicted based on both clinical and public health interventions.
References
1. World Health Organization. Novel Coronavirus (2019-nCoV): Situation Report, 11. Geneva, Switzerland: World Health Organization; 2020. [Report]
2. Worldometers. COVID-19 Coronavirus Pandemic. Reported Cases and Deaths by Country or Territory, Countries, Iran. 2021 Feb 19. Available from: https://www.worldometers.info/coronavirus/country/iran/ [Report]
3. Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, et al. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis 2021; 21(4):473-81. [DOI] [PMID] [PMCID]
4. Burki T. Outbreak of coronavirus disease 2019. Lancet Infect Dis 2020; 20(3):292-3. [DOI] [PMID] [PMCID]
5. Pollock AM, Lancaster J. Asymptomatic transmission of covid-19. BMJ 2020; 371:m4851. doi:10.1136/bmj.m4851 [DOI]
6. Jing QL, Liu MJ, Zhang ZB, Fang LQ, Yuan J, Zhang AR, et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Lancet Infect Dis 2020; 20(10):1141-50. [DOI] [PMID] [PMCID]
7. Winter AK, Hegde ST. The important role of serology for COVID-19 control. Lancet Infect Dis 2020; 20(7):755-9. [DOI] [PMID] [PMCID]
8. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med 2020; 17(9):e1003346. [DOI] [PMID] [PMCID]
9. Yong SEF, Anderson DE, Wei WE, Pang J, Chia WN, Tan CW, et al. Connecting clusters of COVID-19: an epidemiological and serological investigation. Lancet Infect Dis 2020; 20(7):809-15. [DOI] [PMID] [PMCID]
10. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020; 20(8):911-9. [DOI] [PMID] [PMCID]
11. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med 2020; 172(9):577-82. [DOI] [PMID] [PMCID]
12. Bouadma L, Lescure FX, Lucet JC, Yazdanpanah Y, Timsit JF. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med 2020; 46(4):579-82. [DOI] [PMID] [PMCID]
13. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020; 26(8):1200-4. [DOI] [PMID]
14. Wu F, Liu M, Wang A, Lu L, Wang Q, Gu C, et al. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med 2020; 180(10):1356-62. [DOI] [PMID]
15. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223):497-506. [DOI] [PMID] [PMCID]
16. Hui DS, Wong PC, Wang C. SARS: clinical features and diagnosis. Respirology 2003; 8 Suppl(Suppl 1):S20-4. [DOI] [PMID] [PMCID]
17. Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr 2020; 63(4):119-24. [DOI] [PMID] [PMCID]
18. Suhandynata RT, Hoffman MA, Kelner MJ, McLawhon RW, Reed SL, Fitzgerald RL. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19. J Appl Lab Med 2020; 5(5):908-20. [DOI] [PMID] [PMCID]
19. Wang Z, Ma W, Zheng X, Wu G, Zhang R. Household transmission of SARS-CoV-2. J Infect 2020; 81(1):179-82. [DOI] [PMID] [PMCID]
20. Shah K, Saxona D, Mavalankar D. Secondary attack rate of COVID-19 in household contacts: a systematic review. QJM 2020; 113(12):841-50. [DOI] [PMID] [PMCID]
21. Moscola J, Sembajwe G, Jarrett M, Farber B, Chang T, McGinn T, et al. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area. JAMA 2020; 324(9):893-5. [DOI] [PMID] [PMCID]
22. Nishiura H, Lintona NM, Akhmetzhanov AR. Serial interval of novel coronavirus (COVID-19) infections. Int J Infect Dis 2020; 93:284-6. [DOI] [PMID] [PMCID]
23. Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19; systematic review, meta- analysis, and meta-regression. J Stroke Cerebrovasc Dis 2020; 29(8):104949. [DOI] [PMID] [PMCID]
24. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia- A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020; 14(4):395-403. [DOI] [PMID] [PMCID]
25. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020; 395(10225):689-97. [DOI]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
